These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

540 related articles for article (PubMed ID: 20525969)

  • 21. Impact of quadruple regimen of clarithromycin added to metronidazole-containing triple therapy against Helicobacter pylori infection following clarithromycin-containing triple-therapy failure.
    Ueki N; Miyake K; Kusunoki M; Shindo T; Kawagoe T; Futagami S; Tsukui T; Inagaki H; Sakamoto C
    Helicobacter; 2009 Apr; 14(2):91-9. PubMed ID: 19298336
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Optimal treatment of Helicobacter pylori with ranitidine bismuth citrate (RBC): a randomized comparison between two 7-day triple therapies and a 14-day dual therapy.
    de Boer WA; Haeck PW; Otten MH; Mulder CJ
    Am J Gastroenterol; 1998 Jul; 93(7):1101-7. PubMed ID: 9672338
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of metronidazole as second-line drug for the treatment of Helicobacter pylori Infection in the Japanese population: a multicenter study in the Tokyo Metropolitan Area.
    Matsuhisa T; Kawai T; Masaoka T; Suzuki H; Ito M; Kawamura Y; Tokunaga K; Suzuki M; Mine T; Takahashi S; Sakaki N
    Helicobacter; 2006 Jun; 11(3):152-8. PubMed ID: 16684262
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Eradication therapies for Helicobacter pylori.
    Borody TJ; Shortis NP; Reyes E
    J Gastroenterol; 1998; 33 Suppl 10():53-6. PubMed ID: 9840019
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [What is currently the Helicobacter pylori eradication therapy of choice? Triple therapy (PPI, amoxicillin and clarithromycin) or sequential therapy (PPI and amoxicillin for 5 days followed by PPI, clarithromycin and metronidazole for a further 5 days)?].
    Sánchez-Delgado J
    Gastroenterol Hepatol; 2009 Jan; 32(1):68-9. PubMed ID: 19174106
    [No Abstract]   [Full Text] [Related]  

  • 26. Treatment of Helicobacter pylori infection.
    Cavallaro LG; Egan B; O'Morain C; Di Mario F
    Helicobacter; 2006 Oct; 11 Suppl 1():36-9. PubMed ID: 16925610
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Attitude facing a patient suffering from Helicobacter pylori infection resistant to a triple therapy.
    Gisbert JP; Pajares JM
    Rev Esp Enferm Dig; 2003 Mar; 95(3):220-8, 210-19. PubMed ID: 12760711
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The efficacy of bismuth containing quadruple therapy as a first-line treatment option for Helicobacter pylori.
    Uygun A; Kadayifci A; Safali M; Ilgan S; Bagci S
    J Dig Dis; 2007 Nov; 8(4):211-5. PubMed ID: 17970879
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evolution of Helicobacter pylori therapy from a meta-analytical perspective.
    Gisbert JP; Pajares R; Pajares JM
    Helicobacter; 2007 Nov; 12 Suppl 2():50-8. PubMed ID: 17991177
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A randomized clinical trial to determine the efficacy of regimens containing clarithromycin, metronidazole, and amoxicillin among histologic subgroups for Helicobacter pylori eradication in a developing country.
    Fischbach LA; Bravo LE; Zarama GR; Bravo JC; Ojha RP; Priest EL; Collazos T; Casabon AL; Guerrero LZ; Singh KP; Correa P
    Helicobacter; 2009 Apr; 14(2):100-8. PubMed ID: 19298337
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of three different second-line quadruple therapies including bismuth subcitrate in Turkish patients with non-ulcer dyspepsia who failed to eradicate Helicobacter pylori with a 14-day standard first-line therapy.
    Uygun A; Ozel AM; Yildiz O; Aslan M; Yesilova Z; Erdil A; Bagci S; Gunhan O
    J Gastroenterol Hepatol; 2008 Jan; 23(1):42-5. PubMed ID: 17559359
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment of Helicobacter pylori infection.
    Miehlke S; Bayerdörffer E; Graham DY
    Semin Gastrointest Dis; 2001 Jul; 12(3):167-79. PubMed ID: 11478749
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Helicobacter pylori diagnosis and management.
    Vilaichone RK; Mahachai V; Graham DY
    Gastroenterol Clin North Am; 2006 Jun; 35(2):229-47. PubMed ID: 16880064
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Helicobacter pylori: diagnosis and treatment.
    Selgrad M; Kandulski A; Malfertheiner P
    Curr Opin Gastroenterol; 2009 Nov; 25(6):549-56. PubMed ID: 19696666
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of Helicobacter pylori infection 2010.
    O'Connor A; Gisbert JP; McNamara D; O'Morain C
    Helicobacter; 2010 Sep; 15 Suppl 1():46-52. PubMed ID: 21054653
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sequential therapy for H. pylori eradication.
    Drug Ther Bull; 2011 Sep; 49(9):102-5. PubMed ID: 21921072
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evidence-based recommendations for successful Helicobacter pylori treatment.
    Wu JY; Liou JM; Graham DY
    Expert Rev Gastroenterol Hepatol; 2014 Jan; 8(1):21-8. PubMed ID: 24410470
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Therapy for Helicobacter pylori infection can be improved: sequential therapy and beyond.
    Graham DY; Lu H; Yamaoka Y
    Drugs; 2008; 68(6):725-36. PubMed ID: 18416582
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of Helicobacter pylori infection 2012.
    Tepes B; O'Connor A; Gisbert JP; O'Morain C
    Helicobacter; 2012 Sep; 17 Suppl 1():36-42. PubMed ID: 22958154
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Helicobacter pylori infection: treatment options.
    Calvet X
    Digestion; 2006; 73 Suppl 1():119-28. PubMed ID: 16498260
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.